Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1980 May;55(5):362–364. doi: 10.1136/adc.55.5.362

Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants.

R S Procianoy, J A Garcia-Prats, H M Hittner, J M Adams, A J Rudolph
PMCID: PMC1626874  PMID: 7436472

Abstract

The relationship between the use of indomethacin, a prostaglandin inhibitor, for closure of patent ductus arteriosus (PDA) and the occurrence of retinopathy of prematurity was investigated retrospectively. 63 preterm infants less than or equal to 1500 g who were less than or equal to 32 weeks' gestational age, appropriate weight for gestational age, with a diagnosis of PDA, and admitted during the first 24 hours of life were studied. Diagnosis of retinopathy was made by retinal examination when each infant was about 4 weeks. Diagnosis of PDA was made by clinical, radiological, and echocardiographic findings. 15 patients were treated with indomethacin because of severe congestive heart failure. There were no differences between gestational ages, birthweights, duration of oxygen therapy, or incidence of retinopathy in treated and untreated patients. We suggest that the use of indomethacin for PDA closure does not increase the incidence of retinopathy in very low birthweight infants.

Full text

PDF
362

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battaglia F. C., Lubchenco L. O. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967 Aug;71(2):159–163. doi: 10.1016/s0022-3476(67)80066-0. [DOI] [PubMed] [Google Scholar]
  2. CLASSIFICATION of retrolental fibroplasia. Am J Ophthalmol. 1953 Oct;36(10):1333–1335. [PubMed] [Google Scholar]
  3. Dubowitz L. M., Dubowitz V., Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970 Jul;77(1):1–10. doi: 10.1016/s0022-3476(70)80038-5. [DOI] [PubMed] [Google Scholar]
  4. Friedman W. F., Fitzpatrick K. M., Merritt T. A., Feldman B. H. The patent ductus arteriosus. Clin Perinatol. 1978 Sep;5(2):411–436. [PubMed] [Google Scholar]
  5. Friedman W. F., Hirschklau M. J., Printz M. P., Pitlick P. T., Kirkpatrick S. E. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976 Sep 2;295(10):526–529. doi: 10.1056/NEJM197609022951003. [DOI] [PubMed] [Google Scholar]
  6. Friedman Z., Demers L. M. Essential fatty acids, prostaglandins, and respiratory distress syndrome of the newborn. Pediatrics. 1978 Mar;61(3):341–347. doi: 10.1542/peds.61.3.341. [DOI] [PubMed] [Google Scholar]
  7. Heymann M. A., Rudolph A. M., Silverman N. H. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976 Sep 2;295(10):530–533. doi: 10.1056/NEJM197609022951004. [DOI] [PubMed] [Google Scholar]
  8. James S., Lanman J. T. History of oxygen therapy and retrolental fibroplasia. Prepared by the American Academy of Pediatrics, Committee on Fetus and Newborn with the collaboration of special consultants. Pediatrics. 1976 Apr;57(Suppl 2):591–642. [PubMed] [Google Scholar]
  9. Kinsey V. E., Arnold H. J., Kalina R. E., Stern L., Stahlman M., Odell G., Driscoll J. M., Jr, Elliott J. H., Payne J., Patz A. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977 Nov;60(5):655–668. [PubMed] [Google Scholar]
  10. Lechner D., Kalina R. E., Hodson W. A. Retrolental fibroplasia and factors influencing oxygen transport. Pediatrics. 1977 Jun;59(6):916–918. [PubMed] [Google Scholar]
  11. Schrager G. O. PDAs, prostaglandins, and RLF. Pediatrics. 1978 Nov;62(5):860–861. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES